Drug Report History #41954
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v11-FR | Version v10-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2018-04-13 | 2018-04-13 |
| Drug Identification Number | 02076306 | 02076306 |
| Brand name | IOPIDINE | IOPIDINE |
| Common or Proper name | IOPIDINE 0.5% SOLN 5ML | IOPIDINE 0.5% SOLN 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC | NOVARTIS PHARMACEUTICALS CANADA INC |
| Ingredients | APRACLONIDINE | APRACLONIDINE |
| Strength(s) | .5% | .5% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | OPHTHALMIC | OPHTHALMIC |
| Packaging size | 5ML | 5ML |
| ATC code | S01EA | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2018-03-06 | 2018-03-06 |
| Estimated end date | 2018-03-29 | 2018-03-29 |
| Actual end date | 2018-04-12 | 2018-04-12 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |